July 30 (Reuters) - BioScrip Inc BIOS.O :
* BIOSCRIP REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS
* BIOSCRIP INC QTRLY NET REVENUE OF $191.5 MILLION, UP 8.9%
COMPARED TO $175.8 MILLION IN Q2 OF 2018
* BIOSCRIP INC - GIVEN PENDING COMBINATION WITH OPTION CARE,
CO
WILL NOT BE PROVIDING BIOSCRIP FINANCIAL GUIDANCE
* BIOSCRIP INC QTRLY LOSS PER SHARE $0.14
* BIOSCRIP INC - LIQUIDITY OF $14.4 MILLION AT JUNE 30,
2019,
CONSISTING OF CASH AND CASH EQUIVALENTS
Source text for Eikon: ID:nGNX8pK4dx
Further company coverage: BIOS.O
((Reuters.Briefs@thomsonreuters.com;))